PyroTec® PRO Automated Endotoxin Testing Solution containing 2 Plate Readers
Pooled 10-donor, female-only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 20-donor, female-only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 10-donor, male human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 20-donor male only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
PowerCHO® 2 Powder kit 100 L, with HEPES, Pluronic® F-68, without L-Glutamine, Phenol red, hypoxanthine or thymidine
PowerCHO® 2 Powder Kit 10L, chemically defined, with HEPES, Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine
PowerCHO® 2 Powder Kit 50 L, chemically defined, with HEPES, Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine
PowerCHO® 2 Powder Kit 500 L, chemically defined, with HEPES, Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine
Pooled 50-donor, mixed gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
-
CHO Media PortfolioMaximize Your Protein Expression With Our CHO Media
-
TheraPRO® CHO Media SystemToss sheet used to promote the TheraPRO CHO Media System
-
CHO Introduction Customer Facing PresentationFor sales to use when presenting CHO to customers/prospects
-
TheraPRO® CHO Instructions for UseInstructions on how to use the TheraPRO® CHO Media System
-
4D-Nucleofector® Protocol for CHO-K1Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for CHO-K1
-
TheraPRO® CHO Scalability Therapeutic Protein Production, SimplifiedWhitepaper focusing on the scalability of the TheraPRO® CHO expansion medium
-
CHO-K1 Transfection Protocol - 4D-Nucleofector™ DeviceInstructions of use for transfection of CHO-K1 cells with the SF Cell Line 4D-Nucleofector™ X Kit
-
BE02-056Q CHO Xtreme™ Feed CD - InstructionsBE02-056Q
-
eCHO® Basal Medium and eCHO® Feed Product InformationChemically defined serum-free CHO medium for fed-batch cell culturing
-
TheraPRO® - Asset - User Instructions V7TheraPRO® CHO IFU